From: MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer
n (%) | MYC | p- value | FBXW7 | p- value | TP53 | p- value | |
---|---|---|---|---|---|---|---|
Median ± IQR | Median ± IQR | Median ± IQR | |||||
Age (y) (mean ± SD) | |||||||
>50 (65.3 ± 9.1) | 19 (57.6%) | 2.04 ± 1.35 | 0.8873 | 0.55 ± 0.37 | 0.9247 | 0.86 ± 0.62 | 0.7409 |
≤50 (42.1 ± 8.2) | 14 (42.4%) | 1.44 ± 4.88 | 0.53 ± 0.50 | 0.94 ± 1.65 | |||
Gender | |||||||
Male | 15 (45.5%) | 2.01 ± 1.01 | 0.4065 | 0.53 ± 0.22 | 0.6353 | 0.89 ± 0.58 | 0.8125 |
Female | 18 (54.5%) | 1.67 ± 2.03 | 0.56 ± 0.56 | 0.87 ± 0.69 | |||
Histopathology | |||||||
Intestinal | 22 (66.7%) | 2.06 ± 0.99 | 0.3525 | 0.53 ± 0.16 | 0.1391 | 0.81 ±0.78 | 0.3311 |
Diffuse | 11 (33.3%) | 1.40 ± 2.32 | 0.77 ±0.74 | 0.94 ± 0.38 | |||
Depth of tumor invasion | |||||||
T1 | 6 (18.2%) | 0.89 ± 0.47 | 0.0857 | 0.88 ± 0.58 | 0.0678 | 0.85 ± 0.15 | 0.7069 |
T2-T4 | 27 (81.8%) | 2.08 ± 1.42 | 0.53 ± 0.43 | 0.91 ± 0.79 | |||
Lymph node metastasis | |||||||
Absent | 13 (39.4%) | 0.98 ± 1.09 | 0.0225* | 0.68 ± 0.36 | 0.0238* | 0.84 ± 0.44 | 0.6121 |
Present | 20 (60.6%) | 2.10 ± 2.20 | 0.46 ± 0.38 | 0.94 ± 0.79 | |||
Stage | |||||||
I-II | 18 (54.5%) | 1.39 ± 1.23 | 0.0362* | 0.57 ± 0.38 | 0.0380* | 0.83 ± 0.55 | 0.0892† |
III-IV | 15 (45.5%) | 2.41 ± 2.79 | 0.34 ± 0.45 | 0.96 ± 1.19 | |||
MYC IHC | |||||||
Positive | 20 (60.6%) | 2.18 ± 1.59 | 0.0022* | 0.53 ± 0.32 | 0.4090 | 0.81 ± 0.57 | 0.1372 |
Negative | 13 (39.4%) | 0.89 ± 0.85 | 0.58 ± 0.53 | 0.99 ± 0.90 | |||
p53 IHC | |||||||
Positive | 7 (21.2%) | 4.25 ± 6.53 | 0.0891 | 0.64 ± 0.68 | 0.9203 | 1.06 ± 0.83 | 0.2937 |
Negative | 26 (78.8%) | 2.00 ± 1.44 | 0.55 ± 0.35 | 0.87 ± 0.60 |